Navigation Links
Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial
Date:2/11/2008

he science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the- counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC.

For more information, please visit Phosphagenics' web site at http://www.phosphagenics.com.

About Nestle Nutrition

Nestle Nutrition is an autonomous business within the Nestle group managing and developing the group's speciality nutrition brands. Through science-based nutrition products and services, Nestle Nutrition helps enhance the quality of people's lives by supporting health and providing care for specific consumer groups with special nutrition needs at every stage of life.

About 22 000 employees in more than 70 markets are part of Nestle Nutrition. Its product portfolio -- covering infant nutrition, healthcare nutrition, performance nutrition and weight management -- includes such trusted and well-recognised brands as: NAN, GERBER, LACTOGEN, NESLAC, CERELAC, BOOST, NUTREN, PEPTAMEN, RESOURCE, OPTIFAST, POWERBAR, MUSASHI and JENNY CRAIG.

For more information, please visit Nestle Nutrition' web site at http://www.nestlenutrition.com.

About the Phosphagenics / Nestle Pre-Clinical Studies

The final results of the two pre-clinical dose
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
5. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
6. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
11. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Pa. , July 29, 2015 ... UNS), a developer, manufacturer and supplier of injectable ... the Imperium™ platform of instant patch pumps for ... disposable, multi-day wearable insulin pump that does not ... it is prefilled and pre-assembled like an insulin ...
(Date:7/29/2015)... , July 29, 2015 Varian Medical Systems, ... through one of its European subsidiaries, agreed to acquire ... of components and subsystems for X-ray imaging equipment manufacturers. Varian,s ... pay approximately €50 million in cash for Claymount. The ... Claymount is one of the world,s leading ...
(Date:7/29/2015)... July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... 30, 2015. For the second quarter of 2015, the Company reported ... compared to a net loss of $13.4 million, or $0.18 loss ... months ended June 30, 2015, the Company reported a net loss ... net loss of $25.2 million, or $0.35 loss per share, for ...
Breaking Medicine Technology:Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9
... May 11, 2011 As one of the first ... Swedish is home to the fastest growing, most comprehensive ... established the multidisciplinary, robotic-assisted surgical program in 2005 and ... more than any other program in the region. ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... care and gastroenterology markets, today announced that it will ... Specialty Pharmaceuticals Conference in London on Wednesday, May 25, ... will be simultaneously webcast and can be accessed by ...
Cached Medicine Technology:Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 2Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 3Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 4Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 5Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 6Swedish Robotic-Assisted Surgical Program Grows, Continues to Gain Momentum 7
(Date:7/29/2015)... ... ... According to The Spirits Business on July 16th, a new study ... perpetuating alcohol use disorders. Humans have the same gene, which is called Rsu1. The ... and has given researchers inklings to explore Rsu1 in humans to abate alcohol addiction ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... anticipating testing regulations imposed by the FDA for nicotine laced liquid products. Their ... electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... Michigan, changed its name in July to Kalamazoo Strength & Conditioning. , The ... , and “reflects the evolution of our training center over the past three ...
(Date:7/29/2015)... , ... July 29, 2015 , ... San Fernando ... on Ultherapy. For a limited time only, patients can get the complete treatment process ... for patients who prefer a non-invasive treatment and have loose or sagging skin. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... For the ... to be featured in the list of the 50 fastest growing companies in Jacksonville. ... around the business community. On July 16th, a team of Vast Bridges staffers were ...
Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Vast Bridges Continues Its Swift Growth 2
... doctor and five Bulgarian nurses who have been accused of ... capital, Tripoli. ,Three parents appeared on Tuesday with ... .They identified the five Bulgarian women as the nurses who ... in a Benghazi hospital in 1998. ,In 1999, ...
... According to a research conducted by Stephanie Chiuve it was ... heart ailments//. ,U.S. researchers stated that patients suffering ... their lifestyle. ,It was discussed that middle aged ... maintain a proper diet and change their drinking and smoking ...
... estimated obesity-related risk factors have indicated that more the ... health risks// like hypertension, diabetes and hypercholesterolemia. ... in predisposing women to major health risks – researchers ... and treatment are typically based on body mass index ...
... a study published in the Journal of the National ... suffer from premature menopause//. ,Ovarian irradiation and ... most common risk factors associated with early menopausal symptoms. ... with cancer will survive long-term. Survivors have an increased ...
... offer protection against the late, or adult onset of diabetes//. ... by the University of Minnesota has explained that they have ... apparent effect, but they said, that it could be possible ... rich amounts in the coffee bean may be effecting favourably ...
... that the number of sexually transmitted infections is on a ... there was a 3 percent rise in the diagnosis of ... was reported in syphilis cases at 23 percent, but Chlamydia, ... of gonorrhea fell by 13 percent. The highest increase again ...
Cached Medicine News:Health News:Obese Women are more likely to suffer from Major Health Risks 2Health News:Obese Women are more likely to suffer from Major Health Risks 3Health News:Decaffeinated Coffee Might Protect Against Adult Onset Of Diabetes 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Auto Suture™ ENDO ... of five (5) atraumatic ... in a variety of ... colorectal and other endoscopic ...
The Auto Suture&trade ENDO RETRACT&trade Maxi instrument has application in a variety of general, thoracic, gynecologic, urologic, and endoscopic procedures for temporary retracting of tissue and sma...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
Medicine Products: